
Clinical guidelines for primary sclerosing cholangitis 2017
Author(s) -
Hiroyuki Isayama,
Susumu Tazuma,
Norihiro Kokudo,
Atsushi Tanaka,
Toshio Tsuyuguchi,
Takahiro Nakazawa,
Kenji Notohara,
Suguru Mizuno,
Nobuhisa Akamatsu,
Masahiro Serikawa,
Itaru Naitoh,
Yoshiki Hirooka,
Toshifumi Wakai,
Takao Itoi,
Tomoki Ebata,
Shinji Okaniwa,
Terumi Kamisawa,
Hiroki Kawashima,
Atsushi Kanno,
Keiichi Kubota,
Masami Tabata,
Michiaki Unno,
Hajime Takikawa
Publication year - 2018
Publication title -
journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.33
H-Index - 114
eISSN - 1435-5922
pISSN - 0944-1174
DOI - 10.1007/s00535-018-1484-9
Subject(s) - medicine , primary sclerosing cholangitis , hepatology , nice , epidemiology , flow chart , delphi method , medline , family medicine , disease , intensive care medicine , statistics , mathematics , engineering drawing , computer science , law , political science , engineering , programming language
Background Primary sclerosing cholangitis (PSC) is relatively rare disease and pathogenesis and methods of treatments were still not established. Then, we had conducted the making clinical guidelines to manage patients with PSC based on the literature review and expert opinions. These clinical guidelines were made for the medical doctors on the management of PSC, except child case of PSC. Methods We had employed modified Delphi method. The production committee decided guidelines, strength of recommendations and evidence level after reviewed literatures systematically, and The Expert panel evaluated those. The Scientific Committee of the Japan Biliary Association (JBA) evaluated revised guidelines, and the Public comments were collected on web site of JBA. Results We had made 16 guidelines about epidemiology/pathophysiology, diagnostics, therapy and prognosis. Also, we had made both diagnostic and therapeutic flow chart. Conclusions We hope that these guidelines will contribute to the improvement and development of the medical care of PSC.